ArticleScientific reports2022

Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer.

Erica K Barnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.